| SC 13G/A | 2022-02-10 | ELI LILLY & Co | Forma Therapeutics Holdings, Inc. | 339,191 | 0.7% | EDGAR |
| SC 13G | 2022-02-10 | ELI LILLY & Co | Immunocore Holdings plc | 2,548,145 | 5.8% | EDGAR |
| SC 13G/A | 2022-02-09 | VANGUARD GROUP INC | ELI LILLY & Co | 69,261,754 | 7.2% | EDGAR |
| SC 13G/A | 2022-02-08 | BlackRock Inc. | ELI LILLY & Co | 63,877,023 | 6.7% | EDGAR |
| SC 13G/A | 2022-01-27 | LILLY ENDOWMENT INC | ELI LILLY & Co | 107,463,810 | 11.2% | EDGAR |
| SC 13G | 2021-12-13 | ELI LILLY & Co | Foghorn Therapeutics Inc. | 4,000,000 | 9.7% | EDGAR |
| SC 13G | 2021-09-10 | ELI LILLY & Co | ProQR Therapeutics N.V. | 3,989,976 | 5.6% | EDGAR |
| SC 13G/A | 2021-02-12 | PNC FINANCIAL SERVICES GROUP, INC. | ELI LILLY & Co | 52,012,151 | 5.4% | EDGAR |
| SC 13G | 2021-02-12 | ELI LILLY & Co | Sigilon Therapeutics, Inc. | 2,744,443 | 8.8% | EDGAR |
| SC 13G | 2021-02-12 | ELI LILLY & Co | Avidity Biosciences, Inc. | 2,319,396 | 6.2% | EDGAR |
| SC 13G | 2021-02-12 | ELI LILLY & Co | AC Immune SA | 3,615,328 | 5.0% | EDGAR |
| SC 13G/A | 2021-02-10 | VANGUARD GROUP INC | ELI LILLY & Co | 68,661,494 | 7.2% | EDGAR |
| SC 13G/A | 2021-01-29 | BlackRock Inc. | ELI LILLY & Co | 58,811,768 | 6.1% | EDGAR |
| SC 13G/A | 2021-01-21 | LILLY ENDOWMENT INC | ELI LILLY & Co | 111,132,343 | 11.6% | EDGAR |
| SC 13G | 2021-01-08 | ELI LILLY & Co | PRECISION BIOSCIENCES INC | 3,762,190 | 7.2% | EDGAR |
| SC 13D | 2020-12-22 | ELI LILLY & Co | Prevail Therapeutics Inc. | 18,858,511 | 53.3% | EDGAR |
| SC 13G | 2020-02-14 | PNC FINANCIAL SERVICES GROUP, INC. | ELI LILLY & Co | 52,130,652 | 5.4% | EDGAR |
| SC 13G/A | 2020-02-12 | VANGUARD GROUP INC | ELI LILLY & Co | 70,920,050 | 7.4% | EDGAR |
| SC 13G/A | 2020-02-05 | BlackRock Inc. | ELI LILLY & Co | 60,879,212 | 6.3% | EDGAR |
| SC 13G/A | 2020-01-14 | LILLY ENDOWMENT INC | ELI LILLY & Co | 114,560,599 | 11.9% | EDGAR |